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Abstract We study the biocompatibility, the magnetic clus-
tering, and the possible transfection effect of iron particles
on glia cells. Results indicate that iron particles can coex-
ist quite well with glia cells, and the inductive migration of
the cell through the vanishing of the Fe compound particles
around the cell is examined. Transfection experiments also
prove the feasibility of using iron particles with glia cells.
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1 Introduction
For the past few years, research on iron particles for bio-
medical purposes has been proposed and investigated [1–5].
The passive and active targeting of the nanoparticles pro-
vides a promising application to materials science. These
techniques have been applied to various kinds of cells. To
study the potential application of the Fe2O3 particles for
neural growth, we introduce glia cells (from the mouse) in
the present study. It is well known that the glia cells are the
supporting structure for the central nervous system, and they
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number vastly greater than neuron cells, which are respon-
sible for sending and receiving signals. Therefore, an un-
derstanding of the effects of cations and small particles on
the glia cell is of significant meaning to the bioscientist. In
the following sections, we will focus on the biocompatibil-
ity and the magnetic induction of these particles to the glia
cell. An experiment for injecting the particles into the cell is
under investigation.
2 Materials and Methods
We incubate glia cells of the mouse with part of the stem
cell at 37.5 °C, and the cell count is 97,800 cells. The sizes
of the Fe particles are prepared as 50 nm. However, af-
ter mixing with the medium, a clustering Fe2O3 morphol-
ogy is mostly expected. The molecular mass of Fe2O3 is
159.692 g/mole. Components of the medium (total volume
520 ml) are DMEM (12800-017, GIBCO) 450 ml, fetal
bovine serum 50 ml, penicillin/streptomycin (15140-122,
GIBCO) 5 ml, nonessential amino acid solution (M7145,
Sigma) 5 ml, sodium pyruvate 5 ml. The stock concentra-
tion becomes 7.5 micrograms. The incubation platform is a
35 mm Corning CellBIND®Surface Culture Dish.
We proceed with three experiments to study the feasibil-
ity of the Fe particles. The first one is the biocompatibility
experiment to control the incubation time (T ) and the con-
centration (C) of the particle/medium mixtures. The media
supplied are carefully treated to maintain stabilized condi-
tions for each factor experiment. Particles will cluster to-
gether to form larger entities in the medium. After confirm-
ing the biocompatibility of the particles with glia cells, the
magnetic field inductive migration experiment is performed
as the second experiment. Figure 1 shows the system layout.
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Fig. 1 Magnetic field inside the incubator (units of numerical value in
gauss, by Gauss/Teslameter (F.W. Bell Model 5070)
Table 1 Experiment results for Fe2O3 biocompatibility
T (days) C
25X 50X 100X
3 ++ + ++
7 + + ++
10 + + +
A magnetic source is placed near the incubator disk. The nu-
merical value (units in gauss) is the magnetic flux measured
by the Gauss/Teslameter (F.W. Bell Model 5070).
Biological effects within the magnetic field are to be
observed. After that, the third experiment is the particle
transfection. Nucleofector technology from AMAXA1 is a
transfection technology especially designed for the needs
of difficult-to-transfect cell lines, and is based on a unique
combination of electrical parameters and cell-type-specific
solutions. We try to use this transfection technology to drive
the iron particles into the glia cell and observe the possible
effects.
3 Results and Discussion
For the biocompatibility experiments, Table 1 lists the re-
sults for different incubation times T and particle concen-
trations C. Note that 25X (2 mM), 50X (1 mM) and 100X
(0.5 mM) indicate the diluted ratio compared with the stock
concentration (0.05 M).
Symbol “+” indicates that the cell can coexist well with
the Fe2O3 particles. Figure 2 shows the images for 25X con-
centration with different incubation times. It is clear that the
particles will accumulate on the surface of the cell. This ver-
ifies the first biocompatibility experiment of the Fe2O3 par-
ticles.
Concerning the magnetic induction experiments, the
magnetic field is supposed to form a torque and a force
1http://www.amaxa.com/extras/mailings/basic-nucleofectorsuprsup
-kits/.
Fig. 2 Biocompatibility of Fe2O3 particles with glia cell
(a) Particles within cells under C=5X concentration
and 6 days
(b) Particles disappear around the cells
Fig. 3 Magnetic induction experiments
on the cell surface. However, we have used a 400 gauss
magnetic flux act on the incubator and realize that it cannot
produce significant migration of the cell. In spite of this, the
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(a) Glia cell conditions after 9 hours
(b) Glia cell conditions after 4 days
Fig. 4 Transfection experiment using Fe2O3 particles with glia cell
particles can be guided by the magnetic field to attach on the
surface of the cell. Furthermore, we found that parts of the
particle might penetrate into the cell under a longer incuba-
tion time. Figure 3(a) gives the images for 5X concentration
after a 16-day-long incubation. Also, it is interesting to see
that there exist clearing regions such that the numbers of par-
ticles vanish around the bodies of the cells under different
concentrations.
The locations of these cells are arbitrary in the incubators,
indicating that this is an overall phenomenon. The magnetic
source is located on the left side for all these images, and
no such phenomenon occurs if there is no magnetic source
(Fig. 2). Therefore, the interaction of the particles carried by
the cell results in a more complicated interaction mode with
the magnetic field, which required further investigation.
As for the transfection experiments, results indicate that
the Fe2O3 particles might result in damage to the cell. How-
ever, some part of the glia cell is still alive after the transfec-
tion procedures. The control experiment (without the parti-
cles) had verified that all the glia cells are under normal mor-
phology in the incubation system. The primitive conjecture
is that the Fe2O3 particles will interact with the membrane
of the glia cells. We compare the results after 9 hours and af-
ter 4 days, and confirm that the glia cell can survive after the
transfection operation (see Fig. 4). On the other hand, the
effect of the magnetic field on the iron particles is basically
in a creeping mode; therefore, there is no biological damage
from the magnetic field to the cells.
4 Conclusion
We report that Fe2O3 particles are robust materials for the
three biophysics applications: biocompatibility, magnetic
induction, and transfection of the particles to the glia cell.
We also observe that part of the stem cell can coexist well
in an environment that is full of Fe2O3 particles. This en-
courages us to think that the Fe2O3 material could serve as
a feasible carrier for stem cell targeting experiments in the
future.
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